Medirom Files Long-Delayed 20-F: Going Concern, JPY3.6bn Loss, Nasdaq Delisting Appeal
MRM is trading near its 52-week low of $0.245 (7.8% above the low).
Summary
Medirom filed its overdue FY2025 20-F, disclosing a JPY3.6 billion net loss, substantial going-concern doubt and unremediated material weaknesses, while appealing a November 13 Nasdaq delisting determination.
Key Events · Earnings and Guidance · MRM
-
Overdue 20-F Finally Filed
The FY2025 annual report was filed November 18, 2026, after a Form 12b-25 late-filing notice on April 30, 2026 and a Nasdaq extension that expired November 12, 2026.
-
Going Concern and JPY3.6bn Loss
FY2025 brought a net loss of JPY3,642,581 thousand, a working capital deficit of JPY3,244,164 thousand, a shareholders' deficit of JPY2,623,771 thousand and cash of JPY91,979 thousand; the auditor included a going-concern explanatory paragraph.
-
JPY2.55bn Impairment Wipes Out Goodwill
Impairment losses on long-lived assets and goodwill reached JPY2,550,953 thousand versus JPY22,872 thousand in FY2024, including JPY346,626 thousand of goodwill impairment that reduced goodwill to zero.
-
Material Weaknesses Unremediated
Five material weaknesses in internal control over financial reporting, including one over the going-concern assessment, remained unremediated as of December 31, 2025.
Analysis · MRM · Trade & Services
Medirom finally filed its FY2025 annual report on November 18, 2026 — nearly seven months late — the document Nasdaq was waiting for after issuing a delisting determination on November 13. The filing removes one delisting trigger but reveals how bad the underlying business is: a JPY3,642,581 thousand net loss, a JPY3,244,164 thousand working capital deficit, a JPY2,623,771 thousand shareholders' deficit and only JPY91,979 thousand of cash, with the auditor adding a going-concern paragraph. Impairments of JPY2,550,953 thousand wiped out all goodwill and most store operating rights, and five material weaknesses in internal controls remain unremediated. A Nasdaq Hearings Panel hearing has been requested, but that request stays any suspension for only 15 days, so the listing itself is still in play.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 52.4% of the 208 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.91%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MRM was trading at $0.26 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $2.2M. The 52-week trading range was $0.25 to $2.33. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.